Overview:

As per the Medical Device User Fee and Modernization Act (MDUFMA IV) of 2017, the Food and Drug Administration has updated the lists of Medical Device User Fees for Fiscal year 2021. This comes in effect from 1st October 2021 and includes raising costs of 7% for Premarket submissions including PMA, 510(k) and De Novo requests and IVDs, it rises by 6%.

Establishment registration increases from $5,236 to $5,5467 for standard and small businesses.

Standard FDA Medical Device user fees

Application Type

FYE 2020 (USD)

FYE 2021 (USD)

510 (k)11,59412,432
513 (g)4,6034,936
PMA340,995365,657
De Novo102,299109,697
Panel-track Supplement255,747274,243
180-Day Supplement51,14954,849
Real-time supplement23,897025,596
PMA Annual Report11,93512,798
30 Day notice5,4665,851

Small Business program

Under the CDRH’s Small Program Business Program, small businesses (that is, manufacturers having the gross receipt of $100 million or less), FDA revises the MDUFMA-IV with an increase of 7% in the fiscal year 2021.

 Application Type

FYE 2020 (USD) 

FYE 2021 (USD) 

510 (k)2,8993,108
513 (g)2,3022,468
PMA85,24991,414
De Novo25,57527,424
Panel-track supplement63,93768,561
180-day supplement12,78713,712
Real-time supplement5,9686,399
PMA Annual Report2,9843,200

About Global Regulatory Partners

Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices and pharmaceutical companies globally. GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, Mexico and Argentina. GRP helps many life science companies register their products in different countries in compliance with local regulations.  To learn more, please contact us at  info@globalregulatorypartners.com

Stay in the regulatory Loop: Follow GRP on Social Media

Share This Post: